Antibodies, Monoclonal, Murine-Derived Concept

Vocabulary Service

MeSH

Overview

subject area of

A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura Conferences
A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab Journal Articles
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia Journal Articles
Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma Journal Articles
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis Journal Articles
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma Journal Articles
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group Journal Articles
Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group Journal Articles
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors Journal Articles
Childhood Immune Thrombocytopenia: A Changing Therapeutic Landscape Journal Articles
Conference abstracts of a new oncology drug do not always lead to full publication: Proceed with caution Journal Articles
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura Journal Articles
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12^* Journal Articles
Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma Journal Articles
First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma Journal Articles
Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness Journal Articles
Immunotherapies in Dermatologic Disorders Journal Articles
Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma Journal Articles
Life‐threatening hemolytic anemia due to an autoanti‐Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination Journal Articles
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia Journal Articles
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia Journal Articles
Mixed Variant Multicentric Castleman Disease Treated With Rituximab: Case Report Journal Articles
Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia Journal Articles
New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses Journal Articles
Outcomes of MYC‐associated lymphomas after R‐CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704 Journal Articles
Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma Journal Articles
Positioning new treatments in the management of immune thrombocytopenia Journal Articles
Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report Journal Articles
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia Journal Articles
Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario Journal Articles
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura Journal Articles
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis Journal Articles
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Journal Articles
Successful treatment of multiply relapsed lymphoma with rituximab as a single agent Journal Articles
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura Journal Articles
The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts Journal Articles
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases Journal Articles
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia Journal Articles
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura Journal Articles
Thrombotic thrombocytopenic purpura in pediatric patients. Journal Articles
Thrombotic thrombocytopenic purpura: 2008 Update Journal Articles
Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma Journal Articles
Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy Journal Articles
Use of anti‐CD20 antibody in the treatment of post‐transplant glomerulonephritis Journal Articles